SEVERE WX : Red Flag Warning View Alerts
STREAMING NOW: Watch Now

FDA to broaden access to medication-assisted treatment for opioid addiction

The Food and Drug Administration expects to roll out guidance on expanded access to opioid addiction therapy ...

Posted: Feb 26, 2018 6:12 PM
Updated: Feb 26, 2018 6:13 PM

The Food and Drug Administration expects to roll out guidance on expanded access to opioid addiction therapy known as medication-assisted treatment, Health and Human Services Secretary Alex Azar announced Saturday at a meeting of the National Governor's Association.

As a practice, such treatment utilizes behavioral therapy as well as medications like buphrenorphine and methadone that can reduce cravings and withdrawal symptoms from opioid use. Many addiction specialists consider it the gold standard of addiction treatment.

Many addiction specialists favor medication-assisted treatment

Azar: Not offering such treatment is "like treating an infection without antibiotics"

"Medication-assisted treatment works. The evidence on this is voluminous and ever-growing," Azar said.

His comments were a stark contrast to those of his predecessor Tom Price, who said of such treatment, "If we're just substituting one opioid for another, we're not moving the dial much."

Azar pointed out that just one-third of specialty addiction treatment programs in the United States offer the therapy. "Failing to offer (medication-assisted treatment) is like treating an infection without antibiotics," Azar said, vowing to increase those numbers.

As part of the effort, Azar announced that the FDA would soon be issuing guidance to encourage the development of longer-acting formulations of current therapies. The FDA has approved methadone, naltrexone and buprenophine for the treatment of opioid use disorder. However, one of the barriers to effective treatment, according to addiction specialists, is that these drugs require commitment to consistent and constant administration.

"Injections make adherence easier. You only need a shot once a month rather than going to get it every day. But they also can be more feasible in rural settings, where the opioid crisis has hit especially hard and yet treatment options can be especially sparse," Azar said.

He noted that the FDA recently approved a one-month injectable version of buphrenorphine and said he hopes the upcoming FDA guidance would help encourage the creation of other injectable forms of the drug.

"FDA's guidance will help clarify what kind of evidence is needed to gain approval for new ... forms of buprenorphine, such as data regarding how quickly the drug is distributed in the bloodstream," Azar said.

The secretary also announced that the FDA would soon be issuing guidance around studies that evaluated the effectiveness of medication-assisted treatment.

"The guidance will correct a misconception that patients must achieve total abstinence in order for MAT to be considered effective," Azar said. He explained that other targets aside from abstinence would be considered when evaluating therapies, such as how treatment is impacting emergency-room visits or overdoses.

Addiction specialist Dr. Andrew Kolodny was optimistic but cautious of the announcement. "The changes mentioned for determining effectiveness of new medicines make sense. And we can certainly use more tools in the toolkit. But we don't want FDA to go so far that ineffective medications get approved," said Kolodny, a co-director of the Opioid Policy Research Collaborative at the Heller School at Brandeis University.

Caleb Banta-Green, a researcher at the University of Washington's School of Public Health, said the issue wasn't a need for more treatments but more access. "We have pretty good medications now. The real problem is deploying them to the 80%-plus who want them and can't access them through our complicated health care system."

Kolodny agreed. "We already have effective medications for treating opioid addiction. Buprenorphine works. It's the first-line treatment, but access is inadequate. Not enough doctors are prescribing it. Until we do a better job of improving access to the treatments we have, overdose deaths are likely to remain at historically high levels."

According to the Centers for Disease Control and Prevention's most recent data on drug overdoses, more than 42,000 people died from opioid drug overdoses in 2016, much of it driven by the rapid rise in use of synthetic opioids like illicit fentanyl.

Oregon Coronavirus Cases

Data is updated nightly.

Confirmed Cases: 32994

Reported Deaths: 547
CountyConfirmedDeaths
Multnomah7204138
Marion469594
Washington454060
Umatilla298741
Clackamas242061
Malheur163327
Lane123417
Jackson11615
Deschutes85212
Yamhill76213
Jefferson5418
Polk53215
Linn52213
Morrow5056
Lincoln48213
Union4462
Benton3146
Wasco2963
Klamath2802
Hood River2520
Douglas2334
Clatsop2170
Josephine1982
Columbia1791
Coos1570
Baker942
Crook621
Tillamook530
Lake330
Curry310
Wallowa311
Sherman180
Harney120
Grant100
Gilliam80
Unassigned00
Wheeler00

California Coronavirus Cases

Data is updated nightly.

Confirmed Cases: 812711

Reported Deaths: 15633
CountyConfirmedDeaths
Los Angeles2684556515
Riverside589321206
San Bernardino54482925
Orange534481216
San Diego46734776
Kern31994369
Fresno28441382
Sacramento22356406
Santa Clara21241314
Alameda21240406
San Joaquin20245441
Contra Costa16640206
Stanislaus16471356
Tulare15970263
Ventura12775150
Imperial11852317
San Francisco11195101
Monterey995372
San Mateo9897150
Santa Barbara9090113
Merced8872142
Kings765180
Sonoma7412122
Marin6730118
Solano640065
Madera453965
Placer358745
San Luis Obispo356229
Butte283344
Yolo281555
Santa Cruz23609
Sutter170511
Napa169013
San Benito134811
Yuba11537
El Dorado11304
Mendocino93418
Shasta88317
Lassen7400
Glenn5783
Tehama5735
Lake55511
Nevada5377
Colusa5316
Humboldt5088
Calaveras31714
Amador29616
Tuolumne2274
Inyo18815
Mono1662
Siskiyou1650
Del Norte1391
Mariposa752
Plumas500
Modoc270
Trinity160
Sierra60
Alpine20
Unassigned00
Medford
Clear
56° wxIcon
Hi: 97° Lo: 55°
Feels Like: 56°
Brookings
Clear
65° wxIcon
Hi: 77° Lo: 59°
Feels Like: 65°
Crater Lake
Clear
42° wxIcon
Hi: 82° Lo: 45°
Feels Like: 39°
Grants Pass
Clear
48° wxIcon
Hi: 97° Lo: 54°
Feels Like: 48°
Klamath Falls
Clear
42° wxIcon
Hi: 85° Lo: 40°
Feels Like: 39°
Hot and dry week, smoke returns
KDRV Radar
KDRV Fire Danger
KDRV Weather Cam

Community Events

Latest Video

Image

Possible housing solutions after wildfires

Image

Monday, September 28th Evening Weather

Image

Similarities in days had southern Oregonians on edge

Image

Monday, September 28 afternoon weather

Image

Monday, September 28 morning weather

Image

Sunday, September 27 evening weather

Image

Sunday, September 27 morning weather

Image

The initial spread of the Almeda Fire in real-time

Image

Saturday, September 26 evening weather

Image

Saturday, September 26 morning weather